Cargando…
Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a progressive and rare disease without obvious clinical symptoms that shares characteristics with pulmonary vascular remodeling. Right heart failure in the terminal phase of PAH seriously threatens the lives of patients. This review attempts to comprehensivel...
Autores principales: | Yu, Zhijie, Xiao, Jun, Chen, Xiao, Ruan, Yi, Chen, Yang, Zheng, Xiaoyuan, Wang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760698/ https://www.ncbi.nlm.nih.gov/pubmed/35033157 http://dx.doi.org/10.1186/s13020-022-00568-w |
Ejemplares similares
-
Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition
por: Chen, Xing, et al.
Publicado: (2022) -
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension
por: Chen, Yi-Hang, et al.
Publicado: (2022) -
Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022) -
Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension
por: Wang, Tingting, et al.
Publicado: (2020) -
Management of Pulmonary Arterial Hypertension
por: Mayeux, Jennalyn D., et al.
Publicado: (2020)